@article{socie:hal-03584071, TITLE = {{Tafamidis versus liver transplantation as first-line therapy for hereditary transthyretin amyloidosis}}, AUTHOR = {Socie, P. and Benmalek, A. B. and Lallemand, A. L. and Cauquil, C. C. and Rouzet, F. R. and Le Guludec, G. L. and Samuel, D. S. and Adams, D. A. and Slama, Michel and Algalarrondo, V. A.}, URL = {https://u-picardie.hal.science/hal-03584071}, NOTE = {Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology, Paris, FRANCE, AUG 31-SEP 04, 2019}, JOURNAL = {{European Heart Journal}}, PUBLISHER = {{Oxford University Press (OUP)}}, VOLUME = {40}, NUMBER = {1}, PAGES = {646}, YEAR = {2019}, HAL_ID = {hal-03584071}, HAL_VERSION = {v1}, }